Home » Authors » James Etheridge

Articles by James Etheridge

Innogenetics Plans To Raise EUR39M Through Public Offering

Dec. 3, 2003

By James Etheridge

As Part Of Deal, ExonHit Delivers Small-Molecule Target to Allergan

Nov. 26, 2003

By James Etheridge

As Part Of Deal, ExonHit Delivers Small-Molecule Target to Allergan

Nov. 26, 2003

By James Etheridge

Cellectis Signs Fermentas To Manufacturing Deal For I-Sce1

Nov. 19, 2003

By James Etheridge

Cellectis Signs Fermentas To Manufacturing Deal For I-Sce1

Nov. 19, 2003

By James Etheridge

GSK To Terminate Augmentin Formulation Deal With Flamel

Oct. 29, 2003

By James Etheridge

GSK To Terminate Augmentin Formulation Deal With Flamel

Oct. 29, 2003

By James Etheridge

IDM To Coordinate European Project For Cancer Vaccine

Oct. 22, 2003

By James Etheridge

BioProtein Adds Recombinant Vaccines To Product Offerings

Oct. 22, 2003

By James Etheridge

BioProtein Adds Recombinant Vaccines To Product Offerings

Oct. 22, 2003

By James Etheridge

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 13, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for December 13, 2024.
Second insulin receptor offers new therapeutic avenues
BioWorld Science
Investigators at the Helmholtz Institute have shown that inceptor, an inhibitor of the insulin signaling pathway, acted by binding insulin and targeting it for...
Mechanism underlying so-called idiopathic autism inception unveiled
BioWorld Science
Investigators at the Institute for Research in Biomedicine (IRB Barcelona) have unraveled how and why the absence of a neuronal microexon in cytoplasmic...
Keros stock wilts as it halts two dosing arms in hypertension study
BioWorld
After Keros Therapeutics Inc.’s voluntary halt of dosing in two arms of its phase II study in pulmonary arterial hypertension, the company’s stock crumpled after...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.